FDA reviewers found none of 26 Epitalon citations studied Epitalon
Seven of the submitted papers covered Epithalamin, a bovine pineal extract, not the synthetic AEDG tetrapeptide nominated for compounding.
PR
By Priya Raman · Science Reporter
Oct 15 21:48 ETSource: WorldHealth.net
The wire
- 01An FDA July 2026 briefing document reported that none of the 26 published articles submitted to support Epitalon's compounding nomination were about Epitalon; seven concerned the different substance Epithalamin.
- 02Clinicians and pharmacies fielding Epitalon requests should know the widely quoted lifespan figures come from Epithalamin or Thymalin extracts, not the synthetic peptide.
- 03In three rodent studies of Epitalon itself, mean lifespan did not change; telomere claims rest on small cell-culture reports, including a 2025 Brunel paper later corrected for errors in three figures, with no human trial measuring telomerase.
From the source
Read at worldhealth.netDoes Epitalon Extend Lifespan? It Depends Which Substance You Mean
When Epitalon was nominated for the list of substances US compounding pharmacies may use, the people backing it sent FDA 26 published articles as evidence. FDA’s reviewers read them and reported, in a July 2026 briefing document , that none were about Epitalon. Seven were about Epithalamin, a different substance.
